Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
SALT LAKE CITY, Oct. 25, 2017 -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its first quarter ended September 30, 2017, after the stock market closes on Wednesday, November 8, 2017. The Company will hold an investor conference call at 2:30 p.m. Mountain Standard Time (4:30 p.m. Eastern Standard Time) that same day.
Investors interested in participating in the live call can dial (800) 334-0872 from the U.S. International callers can dial (719) 785-1753. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, November 15, 2017, by dialing (844) 512-2921 from the U.S. and entering confirmation code 7273705, or (412) 317-6671 from international locations, and entering confirmation code 7273705.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and anti-aging company dedicated to helping people transform themselves internally and externally at a cellular level. Their scientifically-validated product lines include Protandim® Nrf2 and NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen, Petandim®, AXIO® Smart Energy and the PhysIQ™Smart Weight Management System. LifeVantage (Nasdaq:LFVN) was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
[email protected]
